KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Fixion Fuel: 40 Kovera certificates.
The lab's record shows 40 certificates printed for Fixion Fuel, analysed between 20 Feb 2026 and 10 May 2026, covering 32 products. Median HPLC purity is 99.93%. Kovera graded 40 as a pass and 0 as a fail.
40
certificates
99.93%
median purity
32
products
0
lab verdict: fail
1
failure rules met
What the record shows
RETRIEVED 2 AUGUST 20261 of the 40 certificates meet at least one of our failure rules. They are shaded in the table below. 28 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
32 AS PRINTEDBPC-157 · 3GHK-CU · 2MOTS-C · 2SELANK · 2SEMAX · 2SS-31 · 2THYMOSIN ALPHA 1 · 25 AMINO 1MQ · 1AHK-CU · 1AOD-9604 · 1BPC-157/TB-500 · 1Cagrilintide · 1CJC1296 NO DAC · 1DSIP · 1EPITHALON · 1GHK-Cu · 1GLUTATHIONE · 1hGH (191aa) · 1IGF1-LR3 · 1IPAMORELIN · 1Kisspeptin-10 · 1Klow · 1KPV · 1LL-37 · 1MOTS-c · 1NAD+ · 1SERMORELIN · 1SLU-PP-332 · 1Tesamorelin · 1Thymosin alpha-1 · 1VIP · 1WOLVERINE (BPC/TB4 BLEND) · 1
Every certificate
NEWEST FIRST · 40 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-FFC187 | Cagrilintide | FF-CGL5-0429 | 99.816% | 114.8%5.74 of 5 mg | 10 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8FD2AD | AOD-9604 | FF-AOD5-0407 | 99.836% | 110.2%5.51 of 5 mg | 10 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-DCD4D4 | Kisspeptin-10 | FF-KS10-0407 | 99.924% | 120.6%12.06 of 10 mg | 25 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-A260C3 | Thymosin alpha-1 | FF-TA110-0407 | 99.901% | 110.3%11.03 of 10 mg | 25 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-9372B0 | hGH (191aa) | FF-HGH20-0407 | 99.887% | — | 25 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-913E86 | LL-37 | FF-LL3710-0407 | 99.807% | 115.6%11.56 of 10 mg | 25 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-5860D2 | MOTS-c | FF-MO10-0407 | 99.934% | 98.9%9.89 of 10 mg | 25 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-46CFDE | Klow | FF-KW80-0407 | 99.752% | 107.7%86.16 of 80 mg | 25 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-41D319 | BPC-157 | FF-BP10-0407 | 99.941% | 114.1%11.41 of 10 mg | 25 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-01556B | BPC-157/TB-500 | FF-TB10-0407 | 99.827% | 112.7%22.54 of 20 mg | 25 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-FB0849 | GHK-Cu | FF-HK100-0205 | 99.968% | 110.5%110.53 of 100 mg | 8 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8B59B | WOLVERINE (BPC/TB4 BLEND) | FF-T/B10-0124 | 99.809% | 106.0%21.19 of 20 mg | 8 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8B59A | GLUTATHIONE | FF-GT1500-0226 | 99.964% | 106.7%1599.94 of 1500 mg | 8 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8B599 | CJC1296 NO DAC | FF-CJND10-0113 | 99.928% | 107.2%10.72 of 10 mg | 8 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8B598 | THYMOSIN ALPHA 1 | FF-TA110-0114 | 99.971% | 118.6%11.86 of 10 mg | 8 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8B591 | AHK-CU | FF-AHK100-0226 | 99.952% | 108.2%108.17 of 100 mg | 8 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8B590 | KPV | FF-KPV10-0226 | 99.922% | 109.1%10.91 of 10 mg | 8 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-3D9465 | Tesamorelin | FF-TE10-0208 | 99.933% | 112.6%11.26 of 10 mg | 8 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8B597 | THYMOSIN ALPHA 1 | FF-TA110-1214 | 99.969% | 118.9%11.89 of 10 mg | 7 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8B596 | 5 AMINO 1MQ | FF-51Q50-0125 | 99.983% | 118.8%59.42 of 50 mg | 7 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8B595 | GHK-CU | FF-HK100-0226 | 99.948% | 111.1%111.07 of 100 mg | 7 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8B594 | GHK-CU | FF-HK100-1222 | 99.929% | 107.6%107.58 of 100 mg | 7 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8B593 | DSIP | FF-DS10-1231 | 99.936% | 108.7%10.87 of 10 mg | 7 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8B592 | IGF1-LR3 | FF-IGF1-0226 | 99.969% | 116.0%1.16 of 1 mg | 7 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8B58F | SS-31 | FF-SS10-0103 | 99.966% | 117.3%11.73 of 10 mg | 7 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8B58E | SS-31 | FF-SS10-1121 | 99.983% | 115.4%11.54 of 10 mg | 7 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B04F94 | NAD+ | FF-NA500-0122 | 99.716% | 94.7%473.41 of 500 mg | 3 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-FD8E8B | MOTS-C | FF-MO10-1224 | 99.82% | 134.8%13.48 of 10 mg | 20 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-FC2FD2 | VIP | FF-VIP10-1227 | 99.922% | 148.1%14.81 of 10 mg | 20 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-F73C6A | MOTS-C | FF-MO10-0118 | 99.82% | 127.4%12.74 of 10 mg | 20 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-EEA1F4 | BPC-157 | FF-BP10-0126 | 99.966% | 139.1%13.91 of 10 mg | 20 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-E98260 | SEMAX | FF-SX10-0226 | 99.986% | 124.1%12.41 of 10 mg | 20 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-D94A88 | IPAMORELIN | FF-IP10-0226 | 99.931% | 118.2%11.82 of 10 mg | 20 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-BC7CB6 | BPC-157 | FF-BP10-1227 | 99.962% | 129.4%12.94 of 10 mg | 20 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-BBC931 | EPITHALON | FF-ET10-0226 | 99.974% | 138.4%13.84 of 10 mg | 20 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-9C5127 | SERMORELIN | FF-SMO10-0226 | 99.966% | 118.7%11.87 of 10 mg | 20 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-77AFCD | SELANK | FF-SK10-0226 | 99.976% | 135.4%13.54 of 10 mg | 20 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-724F71 | SELANK | FF-SK10-1216 | 99.934% | 119.7%11.97 of 10 mg | 20 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-549EBD | SLU-PP-332 | FF-SLU5-0226 | 99.927% | 68.7%6.87 of 10 mg | 20 Feb 2026 | PASSunder 90% of label | Kovera ↗our verifier → |
| KVR-2026-3D950F | SEMAX | FF-SX10-1125 | 99.957% | 147.4%14.74 of 10 mg | 20 Feb 2026 | PASSover 110% of label | Kovera ↗our verifier → |